搜索临床试验以:[14C]-AQX-1125IV
总计137个结果
-
Aquinox Pharmaceuticals (Canada) Inc.Quotient Clinical完全的
-
Aquinox Pharmaceuticals (Canada) Inc.Innovaderm Research Inc.完全的
-
Aquinox Pharmaceuticals (Canada) Inc.完全的
-
Aquinox Pharmaceuticals (Canada) Inc.未知间质性膀胱炎 | 疼痛性膀胱综合症 | 膀胱疼痛综合征 | 慢性间质性膀胱炎美国, 比利时, 加拿大, 捷克语, 丹麦, 匈牙利, 拉脱维亚, 荷兰, 波兰, 罗马尼亚, 西班牙, 英国
-
Aquinox Pharmaceuticals (Canada) Inc.终止
-
Aquinox Pharmaceuticals (Canada) Inc.完全的
-
Aptabio Therapeutics, Inc.完全的
-
University of California, San Diego招聘中
-
Kadmon Corporation, LLCQuotient Sciences完全的
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology完全的
-
The University of QueenslandBaxter Healthcare Corporation; Health Research Council, New Zealand; Australian Government Department...完全的
-
Brown UniversityLifespan; SouthCoast Medical Group; Memorial hospital完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的IB 期非小细胞肺癌 AJCC v7 | II 期非小细胞肺癌 AJCC v7 | IIA 期非小细胞肺癌 AJCC v7 | IIB 期非小细胞肺癌 AJCC v7 | IIIA 期非小细胞肺癌 AJCC v7美国
-
Neurocrine BiosciencesTakeda完全的
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)主动,不招人转移性结直肠腺癌 | IV 期结直肠癌 AJCC v8 | IVA 期结直肠癌 AJCC v8 | IVB 期结直肠癌 AJCC v8 | IVC 期结直肠癌 AJCC v8 | III 期结直肠癌 AJCC v8 | IIIA 期结直肠癌 AJCC v8 | IIIB 期结直肠癌 AJCC v8 | IIIC 期结直肠癌 AJCC v8 | BRAF V600E 负极 | KRAS基因突变阴性 | 局部晚期不可切除结直肠腺癌 | NRAS基因突变阴性美国
-
Jonsson Comprehensive Cancer Center完全的
-
Vanderbilt University Medical CenterNational Institutes of Health (NIH); National Institute of General Medical Sciences (NIGMS)终止
-
Children's Oncology GroupNational Cancer Institute (NCI)完全的
-
Theravance BiopharmaGlaxoSmithKline; Hammersmith Medicines Research完全的
-
Cadila PharnmaceuticalsNew Millennium Indian Technology Leadership Initiative (NMITLI) program of Council of Scientific...完全的
-
Emory UniversityNational Cancer Institute (NCI); National Institutes of Health (NIH)主动,不招人解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 浸润性乳腺小叶癌 | 转移性乳腺癌小叶癌美国
-
AstraZeneca完全的
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, France完全的
-
Galera Therapeutics, Inc.完全的